Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.39 USD | -1.29% | -4.72% | -14.58% |
Jun. 04 | Transcript : Kenvue Inc. Presents at 21st Annual dbAccess Global Consumer Conference 2024, Jun-04-2024 02:45 PM | |
May. 23 | Some of the biggest splits in Corporate America | RE |
Business Summary
- health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.);
- body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.);
- other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.).
Product marketing is assured through direct sales, distributors and the Internet.
Number of employees: 22,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Self Care
41.8
%
| 6,030 | 40.3 % | 6,451 | 41.8 % | +6.98% |
Essential Health
29.9
%
| 4,570 | 30.6 % | 4,615 | 29.9 % | +0.98% |
Skin Health and Beauty
28.3
%
| 4,350 | 29.1 % | 4,378 | 28.3 % | +0.64% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
43.8
%
| 6,599 | 44.1 % | 6,767 | 43.8 % | +2.55% |
Europe, Middle East, and Africa
21.9
%
| 3,188 | 21.3 % | 3,388 | 21.9 % | +6.27% |
Asia-Pacific
20.1
%
| 3,146 | 21.0 % | 3,107 | 20.1 % | -1.24% |
Latin America
8.7
%
| 1,198 | 8.0 % | 1,339 | 8.7 % | +11.77% |
North America
5.5
%
| 819 | 5.5 % | 843 | 5.5 % | +2.93% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,919,764,663 | 1,914,390,764 ( 99.72 %) | 4,950,000 ( 0.2578 %) | 99.72 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
McNeil AB
McNeil AB Pharmaceuticals: MajorHealth Technology McNeil AB operates within the consumer health care division that develops and manufactures medicines. It specializes in the manufacture of self-care medicines. The firm offers NICORETTE products for the global market. The company was founded in December 2006 and is headquartered in Helsinborg, Sweden. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.58% | 35.21B | |
+15.68% | 140B | |
+17.79% | 77.03B | |
-3.26% | 72.5B | |
-17.63% | 43.2B | |
+6.89% | 35.09B | |
+13.44% | 18.89B | |
+26.23% | 17.49B | |
+10.03% | 13.01B | |
+17.19% | 9.65B |
- Stock Market
- Equities
- KVUE Stock
- Company Kenvue Inc.